Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical market
Hosein Shabaninejad(Newcastle University), Hamid Reza Rasekh(Shahid Beheshti University of Medical Sciences), Gholamhossein Mehralian(Shahid Beheshti University of Medical Sciences), Arash Rashidian(World Health Organization Regional Office for the Eastern Mediterranean), Ahmad Baratimarnani(Iran University of Medical Sciences)
Cited by 34
Related Papers
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies
|PLoS Medicine|2022|298
Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis
|BMJ Supportive & Palliative Care|2019|203